Cargando…
Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy
Cytokine therapy, involving interleukin-15 (IL-15), is a promising strategy for cancer immunotherapy. However, clinical application has been limited due to severe toxicity and the relatively low immune response rate, caused by wide distribution of cytokine receptors, systemic immune activation and s...
Autores principales: | Wang, Kaiyuan, Zhang, Xuanbo, Ye, Hao, Wang, Xia, Fan, Zhijin, Lu, Qi, Li, Songhao, Zhao, Jian, Zheng, Shunzhe, He, Zhonggui, Ni, Qianqian, Chen, Xiaoyuan, Sun, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598200/ https://www.ncbi.nlm.nih.gov/pubmed/37875481 http://dx.doi.org/10.1038/s41467-023-42155-z |
Ejemplares similares
-
Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials
por: Vijayan, Veena, et al.
Publicado: (2019) -
A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
por: Ni, Qianqian, et al.
Publicado: (2020) -
In Situ Cocktail Nanovaccine for Cancer Immunotherapy
por: Liu, Mohan, et al.
Publicado: (2023) -
A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines
por: Hu, Hanze, et al.
Publicado: (2021) -
A STING-Activating Nanovaccine for Cancer Immunotherapy
por: Luo, Min, et al.
Publicado: (2017)